233 related articles for article (PubMed ID: 25245029)
1. The three-way switch operation of Rac1/RhoA GTPase-based circuit controlling amoeboid-hybrid-mesenchymal transition.
Huang B; Lu M; Jolly MK; Tsarfaty I; Onuchic J; Ben-Jacob E
Sci Rep; 2014 Sep; 4():6449. PubMed ID: 25245029
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
Yamazaki D; Kurisu S; Takenawa T
Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
[TBL] [Abstract][Full Text] [Related]
3. Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis.
Huang B; Jolly MK; Lu M; Tsarfaty I; Ben-Jacob E; Onuchic JN
Sci Rep; 2015 Dec; 5():17379. PubMed ID: 26627083
[TBL] [Abstract][Full Text] [Related]
4. Pigment epithelium-derived factor blocks tumor extravasation by suppressing amoeboid morphology and mesenchymal proteolysis.
Ladhani O; Sánchez-Martinez C; Orgaz JL; Jimenez B; Volpert OV
Neoplasia; 2011 Jul; 13(7):633-42. PubMed ID: 21750657
[TBL] [Abstract][Full Text] [Related]
5. NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.
Ma H; Li T; Tao Z; Hai L; Tong L; Yi L; Abeysekera IR; Liu P; Xie Y; Li J; Yuan F; Zhang C; Yang Y; Ming H; Yu S; Yang X
J Cell Physiol; 2019 Feb; 234(2):1630-1642. PubMed ID: 30159893
[TBL] [Abstract][Full Text] [Related]
6. Increased diacylglycerol kinase ζ expression in human metastatic colon cancer cells augments Rho GTPase activity and contributes to enhanced invasion.
Cai K; Mulatz K; Ard R; Nguyen T; Gee SH
BMC Cancer; 2014 Mar; 14():208. PubMed ID: 24646293
[TBL] [Abstract][Full Text] [Related]
7. Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis.
Chillà A; Margheri F; Biagioni A; Del Rosso M; Fibbi G; Laurenzana A
J Exp Clin Cancer Res; 2018 Apr; 37(1):74. PubMed ID: 29615071
[TBL] [Abstract][Full Text] [Related]
8. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.
Gulhati P; Bowen KA; Liu J; Stevens PD; Rychahou PG; Chen M; Lee EY; Weiss HL; O'Connor KL; Gao T; Evers BM
Cancer Res; 2011 May; 71(9):3246-56. PubMed ID: 21430067
[TBL] [Abstract][Full Text] [Related]
9. FilGAP and its close relatives: a mediator of Rho-Rac antagonism that regulates cell morphology and migration.
Nakamura F
Biochem J; 2013 Jul; 453(1):17-25. PubMed ID: 23763313
[TBL] [Abstract][Full Text] [Related]
10. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101
[TBL] [Abstract][Full Text] [Related]
11. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
Jones BC; Kelley LC; Loskutov YV; Marinak KM; Kozyreva VK; Smolkin MB; Pugacheva EN
Mol Cancer Res; 2017 Jun; 15(6):670-682. PubMed ID: 28235899
[TBL] [Abstract][Full Text] [Related]
12. IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.
Zhang Z; Yang M; Chen R; Su W; Li P; Chen S; Chen Z; Chen A; Li S; Hu C
Oncogene; 2014 Jun; 33(26):3374-82. PubMed ID: 23975422
[TBL] [Abstract][Full Text] [Related]
13. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
[TBL] [Abstract][Full Text] [Related]
14. Carbon-Ion Irradiation Suppresses Migration and Invasiveness of Human Pancreatic Carcinoma Cells MIAPaCa-2 via Rac1 and RhoA Degradation.
Fujita M; Imadome K; Shoji Y; Isozaki T; Endo S; Yamada S; Imai T
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):173-80. PubMed ID: 26279033
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the Rac1/RhoA pathway with ezrin expression in osteosarcoma.
Chiappetta C; Leopizzi M; Censi F; Puggioni C; Petrozza V; Rocca CD; Di Cristofano C
Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):162-70. PubMed ID: 24614149
[TBL] [Abstract][Full Text] [Related]
16. Activin B antagonizes RhoA signaling to stimulate mesenchymal morphology and invasiveness of clear cell renal cell carcinomas.
Wacker I; Behrens J
PLoS One; 2014; 9(10):e111276. PubMed ID: 25343250
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells.
Belgiovine C; Frapolli R; Bonezzi K; Chiodi I; Favero F; Mello-Grand M; Dei Tos AP; Giulotto E; Taraboletti G; D'Incalci M; Mondello C
PLoS One; 2010 Nov; 5(11):e14154. PubMed ID: 21209796
[TBL] [Abstract][Full Text] [Related]
18. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.
Wang H; Quah SY; Dong JM; Manser E; Tang JP; Zeng Q
Cancer Res; 2007 Apr; 67(7):2922-6. PubMed ID: 17409395
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA.
Wang SC; Lin XL; Li J; Zhang TT; Wang HY; Shi JW; Yang S; Zhao WT; Xie RY; Wei F; Qin YJ; Chen L; Yang J; Yao KT; Xiao D
PLoS One; 2014; 9(7):e101330. PubMed ID: 24992599
[TBL] [Abstract][Full Text] [Related]
20. HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells.
Zhao P; Zhang W; Wang SJ; Yu XL; Tang J; Huang W; Li Y; Cui HY; Guo YS; Tavernier J; Zhang SH; Jiang JL; Chen ZN
Hepatology; 2011 Dec; 54(6):2012-24. PubMed ID: 21809360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
